TY - JOUR
KW - Administration, Oral
KW - Adolescent
KW - Adult
KW - Anticoagulants/adverse effects
KW - Aspirin/therapeutic use
KW - *Atrial Fibrillation/complications/drug therapy/epidemiology
KW - *Brain Ischemia/complications
KW - Cohort Studies
KW - Humans
KW - Incidence
KW - Male
KW - Retrospective Studies
KW - *Stroke/epidemiology/etiology/prevention & control
AU - A. Ajabnoor
AU - S. Zghebi
AU - R. Parisi
AU - D. Ashcroft
AU - M. Rutter
AU - T. Doran
AU - M. Carr
AU - M. Mamas
AU - E. Kontopantelis
AD - Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester, United Kingdom.
Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester, United Kingdom.
Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
NIHR Greater Manchester Patient Safety Translational Research Centre (PSTRC), University of Manchester, Manchester, United Kingdom.
Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), The University of Manchester, Manchester, United Kingdom.
Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
Department of Health Sciences, Seebohm Rowntree Building, University of York, York, United Kingdom.
Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, Keele, United Kingdom.
AN - 35671329
BT - PLoS Med
C2 - PMC9173622 following competing interests: DA received research grants from AbbVie, Almirall, Celgene, Eli Lilly, Janssen, Novartis, UCB, and the Leo Foundation.
DO - 10.1371/journal.pmed.1004003
DP - NLM
ET - 2022/06/08
LA - eng
M1 - 6
N1 - 1549-1676
Ajabnoor, Alyaa M
Orcid: 0000-0001-5154-6183
Zghebi, Salwa S
Orcid: 0000-0002-7978-1094
Parisi, Rosa
Orcid: 0000-0002-0968-9153
Ashcroft, Darren M
Orcid: 0000-0002-2958-915x
Rutter, Martin K
Orcid: 0000-0001-6380-539x
Doran, Tim
Orcid: 0000-0001-7857-3704
Carr, Matthew J
Orcid: 0000-0001-7336-1606
Mamas, Mamas A
Orcid: 0000-0001-9241-8890
Kontopantelis, Evangelos
Orcid: 0000-0001-6450-5815
PSTRC-2016-003/DH_/Department of Health/United Kingdom
Journal Article
Research Support, Non-U.S. Gov't
PLoS Med. 2022 Jun 7;19(6):e1004003. doi: 10.1371/journal.pmed.1004003. eCollection 2022 Jun.
PY - 2022
SN - 1549-1277 (Print)
1549-1277
EP - e1004003
T2 - PLoS Med
TI - Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study
VL - 19
ER -